Therapeutic Solutions International, Inc. (TSOI) Stock Price & Analysis
Therapeutic Solutions International, Inc. (TSOI) — price $0.00001 (0.00%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Therapeutic Solutions International, Inc. · TSOI
Therapeutic Solutions International, Inc. (TSOI) specializes in immune system modulation, developing agents for diverse serious conditions including cancers, neurological disorders, and lung pathologies. The company offers patented QuadraMune and a range of nutraceuticals, while also advancing therapeutics for chronic traumatic encephalopathy, traumatic brain injury, and lung diseases.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.00001 | |
| Change on the day | 0.00% | |
| 52-week range | $0.000001 – $0.0001 | |
| Shares traded on the day | 262.5K |
Price & events
Other perspectives
Council score for Therapeutic Solutions International (TSOI): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 6, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: May 7, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On May 7, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Therapeutic Solutions International (TSOI), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Therapeutic Solutions International, Inc. (TSOI) is the company analyzed here. It employs 3 people and is led by Timothy George Dixon. In Q3 FY2024 it reported revenue of $19,667 and net income of -$1M.
What do the latest results show for Therapeutic Solutions International (TSOI)?
Short answer · as of
The most recent reported quarter, Q3 FY2024, carried revenue of $19,667.
Quarterly income statement — 3 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2024 | $19,667 | -$1M | -$0.0002 (diluted) |
| Q2 FY2024 | $20,005 | -$390,046 | -$0.0001 (diluted) |
| Q1 FY2024 | $21,814 | -$585,141 | -$0.0001 (diluted) |
What are the financial strengths and risks for Therapeutic Solutions International (TSOI)?
Short answer · as of
The distress and quality screens read Altman Z -12.18 · Piotroski F 4. Trailing ratios: ROA -65.9% · current ratio 0.05.
The records behind this page
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 12
- Identified insiders
- 2
- Purchases
- 0
- Sales
- 0
- Other transactions
- 12
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held TSOI in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported TSOI in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What Investors Ask About Therapeutic Solutions International (TSOI)
These answers are editorial: 1 of these 1 answer is drawn from the TSOI research dossier (written Jun 14, 2026 by gemini-2.5-flash). Figures in this section are not part of the source register.
What does Therapeutic Solutions International, Inc. do?
Therapeutic Solutions International, Inc. (TSOI) is a biotechnology company focused on modulating the immune system to address a wide spectrum of serious health conditions.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 8 from Financial Modeling Prep (FMP) and 5 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com